As part of our website, we use cookies to provide you with the highest level of service, including services tailored to your individual needs. By continuing to use the website without changing your cookie settings, you agree to the placement of cookies on your device as described in our Privacy Policy. You can change your cookie settings in your web browser at any time. Acceptance of essential cookies is required for the proper functioning of the website. For more detailed information, please refer to our PRIVACY POLICY.

Offer of the Department of Commercialization and Technology Transfer

OFFER

Offer of the Department of Commercialization and Technology Transfer

Chemical Technologies

→ Method of obtaining caprolactam from textile waste containing polyamide 6

→ Recovery of nickel and cadmium from black mass nickel-cadmium batteries

→ Method of recovering zinc and manganese from black mass zinc batteries

→ Method of processing waste Tetra Pak multilayer composites using a binary solvent system

→ Halogen-free polymer composition with limited flammability obtained on the basis of polypropylene

→ Method of disposing of wastewater from the process of manufacturing fatty acid methyl esters→

→ Modified unsaturated polyester resin

→ Method of obtaining modified phenol-formaldehyde resin and a composition that reduces the flammability of plastics

→ Catalytic conversion of biomethanol to biofuels

→ Method of purifying waste wood, especially railroad sleepers, by means of supercritical carbon dioxide extraction

→ Technology for the production of modified thermoplastic starch and biodegradable composites with its participation for the manufacture of disposable products, including films

→ Development of auxiliary raw materials for vinyl polymer processing

→ Method of electroplating copper cross-linked conductive carbon matrices

→ Method of introducing active mass into the current collector of lead-acid battery electrodes

→ Electrochemical way to measure carbon monoxide gas content in hydrogen gas

→ Electrochemical way to recover metals from silicon photovoltaic cells

→ Liquid composition forming an electromagnetic field shielding coating

→ Liquid coating composition designed especially for the manufacture of temporary temperature stabilizing coatings

→ New ammonium ionic liquids, the method of their preparation and their application

→ Halogen-free, self-extinguishing polyurethane-polyisocyanurate foam with improved performance properties and the method of obtaining it

→ Polyamide composites with hybrid silica filler modified with graphene oxide

→ Polyamide composites with aerogel hybrid filler

→ Method of catalytic hydrodechlorination of liquid hydrocarbons

→ Method of regenerating the solvent used in the extraction distillation of mixtures of C4 unsaturated hydrocarbons

Green technologies

→ Method of separating quercetin from onions by extraction

→ Keratin hydrolysate and insoluble keratin carrier structure

→ Biopreparation for plant care

→ Composition of biologically active ingredients of natural origin

→ Biocidal and compostable food packaging

→ Hybrid biocides designed to protect various types of materials exposed to microorganisms

→ Biodegradable composite based on foamed plant biomass possibly with hygienizing properties

→ Method of obtaining chitosan-based films with the addition of fruit peel extract and natural plasticizers

→ Modern biodegradable and/or compostable materials

→ Preparation of biodegradable biopolymer P3HB (BIOBAKCIR)

Pharmaceutical technologies

→ Manufacturing a dietary supplement containing modified-release caffeine

→ Manufacture of the active pharmaceutical ingredient Bimatoprost

→ Manufacture of active pharmaceutical substance Bosentan used in cardiovascular drugs and a medicinal product for the treatment of pulmonary hypertension

→ Manufacture of the active pharmaceutical substance Cilostazol for the treatment of atherosclerosis of inflamed arteries and the technology of the medicinal product

→ Development of a method to obtain derivatives of a cytostatic named MELFALAN

→ Manufacture of the active pharmaceutical substance Eplerenone

→ Manufacture of active pharmaceutical substance Exemestane for the treatment of advanced breast cancer and technology of the pharmaceutical form of the preparation -coated tablets à 25 mg.

→ Construction and expression of a selected recombinant human monoclonal antibody in Escherichia coli bacteria

→ Blocking ELISA for the detection of antibodies to hemagglutinin of influenza viruses serotype H5

→ Work on obtaining recombinant IBV Avian Infectious Bronchitis Virus antigens

→ Molecular basis of structure, physicochemical properties and pharmaceutical form of human insulin and SK3R biotechnology-modified insulin

→ Spectrometric analysis of INSCG(21A)RR insulin analogues at successive stages of production

→ Preparation of recombinant human insulin and its analogues in Escherichia coli IBA cells

→ Prototype vaccine against highly pathogenic H5N1 avian influenza viruses

→ Prokaryotic expression system for recombinant protein production based on Escherichia coli

→ Manufacture of active pharmaceutical ingredient Lapatinib for the treatment of metastatic breast cancer, non-small cell lung cancer, bladder cancer, head and neck cancer and cancers of the digestive system, as well as technology for the manufacture of pharmaceutical form – 250 mg film-coated tablets

→ Manufacture of pharmaceutical active ingredient Loteprednol Etabonate used in ophthalmic drugs and pharmaceutical form – eye suspension

→ Manufacture of active pharmaceutical ingredient Nepafenac for ophthalmic drugs and pharmaceutical form – eye suspension

→ Manufacture of the active pharmaceutical substance Olopatadine used in ophthalmic drugs and the pharmaceutical form of the preparation – eye drops

→ Manufacture of active pharmaceutical substance Pemetrexed and technology of pharmaceutical form – lyophilisate à 100 mg, 500 mg, for the first-line treatment of advanced pleural mesothelioma

→ Manufacture of active pharmaceutical substance Prasugrel for anticoagulant prophylaxis and drug product technology

→ Manufacture of active pharmaceutical substance Sunitinib (in the form of malate) for the treatment of imatinib-resistant gastrointestinal tumors and advanced renal cell carcinoma and technology of pharmaceutical formulation-capsule à 12.5 mg, 25 mg, 50 mg

→ Manufacture of active pharmaceutical substance Temozolomide for glioma chemotherapy and pharmaceutical form – DC capsules containing 5 mg, 20 mg, 100 mg and 250 mg of active substance

→ Manufacture of the active pharmaceutical ingredient Travoprost for use in ophthalmic drugs and the pharmaceutical form of the drug in the form of drops

→ Diosgenin derivatives, the method of obtaining them and pharmaceuticals containing them

Contact
Ewa Śmigiera, PhD. Sc. Eng.
phone +48 22 568 22 43, 22 633 97 98, +48 510 968 563
ewa.smigiera@ichp.lukasiewicz.gov.pl

This will close in 0 seconds

This will close in 0 seconds